---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-111709"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2025-08-27T23:59:59+00:00"
generated_at: "2026-05-17T09:45:07.745498+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Tivic Health appoints Odyssey Transfer as new transfer agent and warrant agent effective Aug 30, 2025

## Summary
- Effective August 30, 2025, Odyssey Transfer and Trust replaces Equiniti as transfer agent and registrar.
- Odyssey will also succeed Equiniti as warrant agent for the Series B Warrants issued on May 13, 2024.
- All registered share records will be transferred from Equiniti to Odyssey on or before the effective date.

## SEC filing metadata
- accession: 0000950170-25-111709
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2025-08-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000095017025111709/0000950170-25-111709-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000095017025111709/tivc-20250827.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-111709
- JSON: https://secwatch.observer/filing/0000950170-25-111709.json
- Plain text: https://secwatch.observer/filing/0000950170-25-111709.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.